Sermorelin 5 mg

Sermorelin is a synthetic 29-amino-acid analog corresponding to the N-terminal active fragment of growth-hormone-releasing hormone (GHRH). It is classified as a GHRH-receptor agonist research peptide used in somatotropic-axis research models.

Through engagement of the GHRH receptor (GHRH-R) on anterior-pituitary somatotrophs, Sermorelin is investigated as a tool compound for studying cAMP/PKA-coupled receptor signaling, downstream growth-hormone-pathway dynamics, and pulsatile somatotropic-axis output in controlled laboratory models. By acting upstream of pituitary GH release rather than as an exogenous hormone, it allows investigators to probe receptor-mediated signaling without overriding endogenous regulatory feedback.

Sermorelin is actively investigated across several research domains, including GHRH-receptor pharmacology, hypothalamic-pituitary-axis signaling research, IGF-1 signaling research, and somatotropic-axis modulation in experimental models. Published research has characterized Sermorelin as a GHRH(1-29) analog that engages GHRH-R-coupled cAMP signaling and supports research into pulsatile growth-hormone-pathway regulation (Prakash & Goa, 1999, BioDrugs). Levels of endogenous GHRH-stimulated somatotropic output are known to decline across age-associated research models, supporting continued investigation of Sermorelin as a receptor-targeted research compound.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

Growth-hormone-releasing hormone is a 44-amino-acid hypothalamic peptide whose N-terminal fragment retains full receptor-binding activity. Early structure-activity research identified GHRH(1-29)-NH2 as the minimum sequence capable of fully engaging the GHRH receptor on pituitary somatotrophs. Sermorelin was developed as a stabilized synthetic analog of this fragment for research use.

Subsequent investigation positioned Sermorelin as a useful tool compound for studying receptor-mediated cAMP/PKA signaling, somatotroph cellular biology, and the pulsatile output characteristic of the somatotropic axis. Because it engages GHRH-R rather than supplying exogenous growth hormone, Sermorelin has been used to investigate receptor-level pharmacology and downstream IGF-1 signaling research in a manner that preserves endogenous feedback dynamics.

This positioning at the intersection of receptor pharmacology, somatotropic-axis research, and IGF-1 signaling research has made Sermorelin a peptide of considerable interest in laboratory investigations of GHRH-receptor signaling and growth-hormone-pathway regulation.

1. GHRH-Receptor Engagement

Sermorelin binds the GHRH receptor (GHRH-R), a class B G-protein-coupled receptor expressed on anterior-pituitary somatotrophs. Receptor engagement activates Gs-coupled adenylate cyclase, elevates intracellular cAMP, and engages PKA-dependent signaling cascades involved in growth-hormone-pathway research.

2. cAMP/PKA Signaling Research

Through cAMP/PKA pathway activation, Sermorelin is investigated as a probe for downstream phosphorylation events, CREB-mediated transcriptional research, and somatotroph cellular signaling in laboratory models of somatotropic-axis regulation.

3. Pulsatile Somatotropic-Axis Modulation

Because Sermorelin engages the same receptor as endogenous GHRH, it is investigated in models where preservation of pulsatile somatotropic output is relevant to receptor-level research, including studies of somatostatin-GHRH balance and age-associated changes in pituitary responsiveness.

4. IGF-1 Signaling Research

By modulating upstream somatotropic-axis activity, Sermorelin is investigated as a tool compound for studying downstream IGF-1 signaling research, including PI3K/Akt and MAPK pathway engagement in cell-culture and animal research models.

Research Applications

Conclusion

Sermorelin represents a structurally defined GHRH(1-29) analog research peptide that engages the GHRH receptor to support investigation of cAMP/PKA-coupled somatotropic-axis signaling. Through receptor-level engagement rather than exogenous hormone supply, it serves as a useful research compound for examining growth-hormone-pathway dynamics, IGF-1 signaling research, and pulsatile receptor output in controlled laboratory models.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.